PhenoPlate™ 384-well microplates (formerly named CellCarrier Ultra microplates) are sterile and tissue culture-treated, with black well walls and an optically-clear cyclic olefin bottom.
PhenoPlate 384-well microplates are designed for cell culture and imaging with high-content screening systems.
false false
These PhenoPlate 384-well microplates (formerly named CellCarrier Ultra microplates) for high content imaging applications are tissue culture treated and are available in black in a 384-well format. The microplates benefit from a film bottom made of cyclic olefin, a plastic that has glass-like optical properties, providing superior image quality and also good cell adherence. They have an ultra-low plate bottom (0.2mm) for better well access when using water immersion and high NA objectives, and a new design, low profile polystyrene lid for reduced evaporation.
Well format: 384-well
Description | Specification |
---|---|
Number of Rows | 16 |
Number of Columns | 24 |
Well volume | 145 µL |
Recommended working volume | 25 µL - 120 µL |
Height (mm) | 14.35 |
Length (mm) | 127.76 |
Width (mm) | 85.48 |
Well diameter (mm) | 3.26 |
Well depth (mm) | 12.7 |
A1 to top offset (mm) | 8.99 |
A1 to side offset (mm) | 12.13 |
Well-to-well spacing (mm) | 4.5 |
自動化兼容 | Yes |
---|---|
塗層處理 | TC-treated |
顏色 | Black with optically-clear film bottom |
檢測方法 | Confocal Imaging, High Content Imaging |
Format | Microplates |
材料 | Cyclic Olefin |
產品品牌名稱 | PhenoPlate (formerly CellCarrier Ultra) |
運輸條件 | 環境 |
Sterile | Yes |
產品尺寸 | Case of 160 |
阱數量 | 384 Wells |
See Clearly with Better Images
From September 15, 2021 CellCarrier Ultra microplates are renamed PhenoPlate microplates. Questions you may have this change can be found in this document.
Technical Note for PhenoPlate-384 Ultra Microplate
With powerful potential for phenotypic drug discovery, cell painting is being rapidly adopted by leading scientists across the globe. However, implementing cell painting assays can present some challenges.
To help you avoid some of the common pitfalls, we’ve collated answers from our expert ...